Brian Alexander feels the current system of drug development is shaped by biotech investor expectations. Valo Health is eschewing that path. The post Valo Health CEO: We Don’t Want Investors To Drive the Science appeared first on MedCity News.
Fernando Viera Reyes necesitaba una biopsia por un posible cáncer de próstata cuando el gobierno de Trump lo envió a un centro de detención de inmigrantes en el desierto de Mojave, en California. Allí, esperó. Reyes, ahora de 51 años, solicitó reiteradas veces el procedimiento, según una demanda presentada en noviembre contra el gobierno federal,…
Fernando Viera Reyes needed a biopsy for possible prostate cancer when the Trump administration sent him to an immigration detention center in California’s Mojave Desert. There, he waited. Reyes, now 51, made repeated requests for the procedure, according to a lawsuit filed in November against the federal government, but months went by even though there…
During a recent interview at the ViVE conference in Los Angeles, Oak HC/FT Partner Vig Chandramouli shared four key trends shaping the health tech startup market, from underinvested labor management, pricing risks and the influence of Epic on long-term deals. The post 4 Health Tech Trends Startups Can’t Ignore, Per an Oak HC/FT Partner appeared…
Navigation program was associated with lower expenditures and hospital-based utilization in both Medicaid and Medicare intervention groups
Coral Care’s Series A round was led by Haymaker Ventures, with participation from FCA Ventures, Peterson Ventures, Alleycorp, Reach Capital, Jefferson River Capital, Greymatter Capital, Mother Ventures and Charge Ventures. The post Coral Care Raises $13M to Scale In-Home Pediatric Therapy appeared first on MedCity News.
This issue brief describes how Medicaid home care operates—including who is eligible and the systems in place to promote program integrity in its delivery—and the challenges of using new CMS data to identify unusual billing patterns or potential fraud in the program.
Slate Medicines’ antibody drug is designed to block PACAP, a protein associated with migraines. The Phase 1-ready asset was licensed from China-based DartsBio Pharmaceuticals. The post Headache Startup Slate Medicines Lands $130M to Bring Novel Migraine Drug Into the Clinic appeared first on MedCity News.
Agency looking to deploy artificial intelligence across both digital and voice channels
Opioid overdose deaths fell sharply from 2023 to 2024 (79,358 to 54,045), driven largely by decreases in fentanyl-involved deaths. Even after these declines, deaths remained above 2019, the year before opioid deaths increased sharply during the pandemic.